Analysing Sepsis Management Part I: Diagnosis

1.1 Research Scope: Sepsis Diagnosis

1.2 Analysis Framework: Frost & Sullivan Core Value

1.3 Research Methodology: Five Steps Toward Success

1.4 Key Findings of Technology Breakthrough Driving Sepsis Diagnosis

2.1 Research Scope: Current Status and Challenges of Sepsis Diagnosis

2.2 Types of Sepsis Diagnosis Tests

3.1 Fundamentals and Epidemiology of Sepsis

3.2 Unmet Needs in Sepsis Management

4.1 Outlook of Sepsis Diagnosis Clinical Trials

4.2 Industry Sponsored Sepsis-Diagnostic Test Clinical Trials

4.3 Non-industry Sponsored Sepsis-Diagnostic Test Clinical Trials in Europe

4.4 Non-industry Sponsored Sepsis-Diagnostic Test Clinical Trials in the Americas, Asia and Rest of the World

4.5 Scholarly Publications Including Patents for Sepsis

5.1 List of COMPANIES in Sepsis Diagnosis

5.2 The US Is The Biggest Hub For Sepsis Diagnosis

5.3 Procalcitonin-based Sepsis Diagnosis

5.4 Procalcitonin and Combination-based Sepsis Diagnosis Technologies

5.5 Sepsis Diagnosis Through Multiple Novel Immunoassays

5.6 Sequencing-based Detection of Sepsis Causing Pathogens

5.7 AI-Sequencing Platforms for Sepsis Causing Pathogen Detection

5.8 Machine Learning AND Host gene expression-based Platforms for sepsis diagnosis

5.9 Mass Spectroscopy-based Sepsis Diagnosis Platforms

5.10 Novel Platforms for Sepsis Diagnosis

5.11 Analyzers and Devices for Sepsis Diagnosis

5.12 Europe: PCR-based Sepsis Diagnosis Platforms

5.13 Americas: PCR-based Sepsis Diagnosis Platforms from big Companies

5.14 Americas: PCR-based Sepsis Diagnosis Platforms from mid-sized Companies

5.15 Americas: PCR-based Sepsis Diagnosis Platforms from small Companies

5.16 Asia: PCR-based Sepsis Diagnosis Platforms

5.17 Sepsis Diagnosis Tests under Development

5.18 Sepsis Diagnosis Companies with Revenue

6.1 Growth Opportunity 1: Selecting the Perfect Test for Specific Need

6.2 Growth Opportunity 2: Business Opportunities Beyond Diagnosis

7.1 Industry Interactions

Legal Disclaimer